Lorcaserin in obesity: minimal benefits and ill-defined harms.

Igho J OnakpoyaJeffrey K Aronson

Published in: BMJ evidence-based medicine (2019)

Keyphrases

insulin resistance
metabolic syndrome
weight loss
high fat diet induced
type diabetes
weight gain
skeletal muscle